ISRCTN31632033已完成不适用
The efficacy and predicting variables of a multidisciplinary disability resolution (MDR) program for Chronic Fatigue Syndrome (CFS) patients receiving long term disability benefits from income protection insurers
niversity Medical Centre St Radboud, Expert Centre Chronic Fatigue (Netherlands)0 个研究点目标入组 130 人开始时间: 2006年4月4日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Extreme fatigue
- •2. Considerable impairment in daily functioning
- •3. Disease (objective finding) - illness (subjective complaints) discrepancy present
- •4. Not older than 45 years
- •5. Receiving disability benefits for a period longer than 3 years
排除标准
- •1. A disease present that can explain the fatigue
- •2. A history of psychosis or schizophrenia
- •3. Primary drugs or alcohol abuse
研究者
相似试验
尚未招募
不适用
The efficacy and predicting variables of a multidisciplinary disability resolution (MDR) program for CFS patients recieving long term disability benefits from income protection insurers.MDRNL-OMON21294WV the Amsterdam & Stichting Embas te Driebergen130
招募中
2 期
Prognostic and effect predictive factors of multimodality treatment for gastric cancerGastric cancerJPRN-UMIN000031060Yokohama Municipal Citizen's Hospital, Division of Gastroenterological Surgery500
已完成
不适用
Performance of the Multidimensional prognostic Index (MPI) based on a comprehensive geriatric Assessment for predicting short- und long-term Mortality in older Patients with acute coronary Syndrom.Acute coronary syndromMultimorbidityI24Other acute ischaemic heart diseasesDRKS00012799niklinik Köln, Klinik und Poliklinik für Innere Medizin II, klinische Altersforschung236
已完成
不适用
Influence and predictive power of the Multidimensional Prognostic Index on the number of primary care physician visits of older, multimorbid patientsGeriatric SyndromesGeriatric ResourcesDRKS00012820niklinik Köln - Zentrum Innere Medizin125
招募中
2 期
The efficacy, safety, and the predictive factors of efficacy of low dose Lenalidomide plus Dexamethasone consolidation therapy followed by very low dose Lenalidomide maintenance therapy for multiple myeloma.multiple myelomaJPRN-UMIN000007785ational Hospital Organization Disaster Medical Center35